There are currently 917 clinical trials in Washington, District Of Columbia looking for participants to engage in research studies. Trials are conducted at various facilities, including Children's National Medical Center, MedStar Georgetown University Hospital, MedStar Washington Hospital Center and Walter Reed Army Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
EndoBarrier System Pivotal Trial(Rev E v2)
NCT04101669
Recruiting
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the EndoBarrier System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the EndoBarrier System plus moderate intensity lifestyle and dietary counseling compliant with 2019 ADA Standard of Care as compared to a sham control receiving moderate intensity... Read More
Gender:
All
Ages:
Between 30 years and 65 years
Trial Updated:
05/09/2023
Locations: MedStar Health Research Institute, Washington, District of Columbia
Conditions: Diabetes type2, Obesity
Register for Updates
Helping Toddlers and Parents Together
NCT04864808
Recruiting
Using stakeholder feedback (i.e., behavioral health providers & caregivers), the goal of this study is to develop a behavioral parenting program that focuses on both parent mental health and parenting for parents of toddlers (12-35 months old). Using a deployment focused intervention model, this study will : (1) develop an early parenting intervention for parents of at-risk toddlers which integrates a focus on parent mental health with evidence-based behavioral parenting strategies, and (2) exam... Read More
Gender:
All
Ages:
Between 12 months and 55 years
Trial Updated:
05/09/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: ADHD, Parenting
Register for Updates
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NCT05268094
Recruiting
COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life.
Gender:
All
Ages:
Between 1 day and 30 days
Trial Updated:
04/12/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Congenital Heart Disease in Children
Register for Updates
PedBot Ankle Rehablitation
NCT05825508
Recruiting
The primary objective of the study is to determine engagement with use and adherence to a home exercise program with our PedBotHome ankle rehabilitation device. We will place the device in the home for 90 days and consider the study a success if used for at least 30 minutes a day for at least 3 days a week during this period.
Gender:
All
Ages:
Between 5 years and 18 years
Trial Updated:
04/11/2023
Locations: Children's National Health System, Washington, District of Columbia
Conditions: Cerebral Palsy
Register for Updates
Vibroacoustic Study of Lung Development in Newborn Infants
NCT05827250
Recruiting
Investigators hypothesize that premature newborns with poor cardiopulmonary performance have higher morbidities and poorer physical and cognitive developmental outcomes. Investigators further hypothesize that audible sounds combined with novel inaudible vibrations above and below human perception interpreted with transparent and auditable AI algorithms can detect and identify early gas and fluid movement anomalies not uncovered by conventional tools in an non-invasive, easy, fast, and low cost... Read More
Gender:
All
Ages:
Between 0 years and 2 years
Trial Updated:
04/11/2023
Locations: Medstar Georgetown University Hospital, Washington, District of Columbia
Conditions: Prematurity, Premature Birth, Premature Lungs, Prematurity; Extreme
Register for Updates
Blue Light Cystoscopy With Cysview® Registry
NCT02660645
Recruiting
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: Sibley Memorial Hospital, Washington, District of Columbia
Conditions: Bladder Cancer
Register for Updates
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183
Recruiting
Post-marketing safety data on patients treated and untreated with eculizumab or ravulizumab.
Gender:
All
Ages:
All
Trial Updated:
03/23/2023
Locations: Clinical Trial Site, Washington, District of Columbia
Conditions: Atypical Hemolytic-Uremic Syndrome
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Gender:
All
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Omalizumab Before Onset of Exacerbations
NCT05332067
Recruiting
OBOE is a prospective, pilot, parallel group RCT with the overall aim of examining the effect of a single dose of anti-IgE (omalizumab) vs. placebo administered at the onset of URIs in the fall season among highly exacerbation-prone, urban, and atopic youth aged 6-17 years with persistent asthma. OBOE will recruit and randomize participants over 3 years (3 annual cohorts of participants). Recruitment for each of the yearly cohorts of OBOE will begin in February. Each cohort will be followed for... Read More
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
03/13/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Asthma in Children, Atopy, Viral Upper Respiratory Infection
Register for Updates
Evaluating the Effectiveness of a Cognitive Behavioral Intervention (CBI)
NCT05782348
Recruiting
This is a Phase III, randomized, one-center, three arm parallel group, open label and single blind clinical study to evaluate the effectiveness of a cognitive behavioral intervention (CBI) adjunctive to a smart powered toothbrush on the oral health of adolescents.
Gender:
All
Ages:
Between 14 years and 17 years
Trial Updated:
03/13/2023
Locations: Friendship Public Charter School, Washington, District of Columbia
Conditions: Adolescent Behavior, Dental Plaque, Gingivitis, Cognitive Change
Register for Updates
Older Breast Cancer Patients: Risk for Cognitive Decline
NCT03451383
Recruiting
The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore change in APE, LM and Cognition domains, measure associations between cognitive decline and QOL, and describe how genetic polymorphisms, inflammatory biomarkers, sleep and physical measures moderate cognitive outcomes. This study is being done nationally, with recruiting sites at Georgetown University, Montgomery General Hospital, Virginia Cancer Specialists, Washington Hosp... Read More
Gender:
Female
Ages:
Between 60 years and 105 years
Trial Updated:
03/09/2023
Locations: Georgetown University, Washington, District of Columbia
Conditions: Cancer, Breast, Age-related Cognitive Decline, Cognitive Decline
Register for Updates
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery
NCT01766492
Recruiting
Quality of life data following SBRT for prostate cancer has been obtained in only a small numbers of patients. A prospective study using validated quality of life questionnaires is needed to determine outcomes after treatment with SBRT. Our study will be the first essential step in developing a better evidence base on the comparative risks and benefits of SBRT treatment with regards to quality of life assessment and outcomes.
Gender:
Male
Ages:
Between 18 years and 99 years
Trial Updated:
02/22/2023
Locations: Georgetown University Hospital, Washington, District of Columbia
Conditions: Prostate Cancer, Localized Malignant Neoplasm
Register for Updates